PharmTech spoke with Ian Bilodeau, managing director, Ardena US about how the expanded use of AI has impacted the ...

Supply chains are being diversified and regionalized to mitigate global disruptions, with significant investments in US ...

In late December 2025, Charles Ross & Son promoted its five-cubic-foot double cone tumbler blender for small- to mid-scale ...

Remco Munnik, Arcana, details pharma's shift to data-first operations, AI adoption, and robust data stewardship.

In an expansion of his written three-part series for PharmTech, Jason Bryant of ArisGlobal explains the interplay between autonomy and accountability that is essential for AI agents assisting the ...

The third and final portion of Bryant’s exclusive video interview with PharmTech ® deals with the processes known as human-in ...

Digital GMP expectations are increasing, driven by Annex 11 and Annex 22, necessitating robust lifecycle management, data ...

Click here to view the Pharmaceutical Technology Europe TM September/October 2025 issue.

Our data show that global pharma M&A is becoming more selective and strategically targeted. While North America remains the ...

Next-generation biologics, such as bispecifics, fusion proteins, and multi-specifics, have multiple functionalities that ...

In an expansion of his written three-part series for PharmTech, Jason Bryant of ArisGlobal explains the interplay between ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...